Ortho Biotech

• NCT00972712

  Collaborator, Phase 1, Completed, 12 people, Sep 7, 2009

• NCT00851552

  Collaborator, Phase 2, Terminated, 9 people, Feb 26, 2009

• NCT00750815

  Collaborator, Phase 1/2, Completed, 58 people, Sep 11, 2008

• NCT00744354

  Collaborator, Phase 1, Terminated, 32 people, Sep 1, 2008

• NCT00635050

  Collaborator, Phase 2, Completed, 32 people, Mar 13, 2008

• NCT00570180

  Collaborator, Phase 2, Completed, 36 people, Dec 10, 2007

• NCT00319150

  Collaborator, Phase 3, Terminated, 6 people, Apr 27, 2006

• NCT00312650

  Collaborator, Phase 2, Terminated, 24 people, Apr 10, 2006

• NCT00307294

  Collaborator, Phase 2, Completed, 40 people, Mar 27, 2006

• Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer

  Collaborator, Phase 2, Completed, 136 people, Mar 15, 2006

• NCT00290433

  Collaborator, Phase 2, Completed, 55 people, Feb 13, 2006

• NCT00244985

  Collaborator, Phase 1/2, Completed, 42 people, Oct 27, 2005

• NCT00220675

  Collaborator, Phase 2/3, Terminated, 7 people, Sep 22, 2005

• NCT00222105

  Collaborator, Phase 2, Completed, 25 people, Sep 22, 2005

• NCT00193037

  Collaborator, Phase 2, Completed, 102 people, Sep 19, 2005

• NCT00184002

  Collaborator, Phase 2, Completed, 68 people, Sep 16, 2005

• NCT00176293

  Collaborator, Phase 2, Terminated, 2 people, Sep 15, 2005

• NCT00101010

  Collaborator, Phase 2, Completed, 80 people, Jan 10, 2005

Sources: clinicaltrials.gov